Telomere attrition can elicit a persistent DNA damage response, thereby activating the ATM/ATR-checkpoint kinase 1 (CHK1) pathway and facilitating immune surveillance evasion by upregulating PD-L1 expression, ultimately promoting tumor cell immune tolerance and progression (36). The gene discussed is CHEK1; the disease is neoplasm.